MarketInOut Stock Screener Log In | Sign Up
 

Nurix Therapeutics Inc

NASDAQ • Healthcare • Biotechnology • Quote as of 10/08/2026 16:00
Nurix Therapeutics Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization2,345.47 mln
Float98.84 mln
Earnings Date02/17/2027

Piotroski F-Score

1 / 9
Very weak

Beneish M-Score

-4.09
Highly reliable

1-Year Forecast

33.93
Exceptional upside

Relative Strength

24 / 100
Significantly lagging

Debt / Equity

0.14
Very low leverage

Pre-Tax Margin

-929%
Severely loss-making

Business Description

Nurix Therapeutics is a clinical-stage drug development company working on new treatments for cancer, autoimmune disorders, and other serious diseases. The company specializes in small molecule drugs that work by breaking down specific proteins that drive illness, with several candidates currently being tested in clinical trials. Nurix works alongside major pharmaceutical partners including Gilead Sciences, Sanofi, and Pfizer to advance its pipeline toward patients. Founded in 2009 and based in Brisbane, California, the company is building on a growing body of research to bring next-generation therapies to market.

Key Fundamentals

EPS-3.46
ROE-76.12
RPS0.37
ROIC-285
ROA-57.12
EBITDA, mln-324
EV / EBITDA-6.80
EV / EBIT-6.46
Revenue, mln36.77
EV / Revenue60.01

Quote Details

Last 22.21
Change -0.52 (-2.29%)
Open 22.49
Volume 2,139,420
Turnover 47,516,516
Average Volume 1,436,379

Financial Ratios

Pre-Tax Profit Margin-929
Leverage Ratio1.33
Current Ratio6.34
Price / Book6.11
Price / Tangible Book6.11
Debt / Equity0.14
Price / Sales63.22

Financial Strength

Altman Z-Score6.83
Piotroski F-Score 1 / 9
Beneish M-Score-4.09
1-Year Target Price33.93
Short Ratio14.59
Short % of Float17.52

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -4.84% 20 / 100   
1 Month -15.42% 16 / 100   
2 Months -7.34% 36 / 100   
6 Months 36.76% 91 / 100   
1 Year 126% 97 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us